5Imbach P. Dapuzzo V, Irth A, et al. High-dose intravenous gammaglobulin for idiophathic throm bocytopenic purpura in childhood[J]. Lancet, 1981,1(8232): 1228.
6Pallack R, Cirami C, Panichi V, et al. Intravenous immunoglobulin therapy of membranous nephropathy: efficacy and safety [J]. Clin Nephrol, 1991,35(1) :98.
1Wiegering V,Schick J,Beer M,et al.Varicella-zoster virus infections in immunocompromised patients-a single centre 6-years analysis.BMC Pediatr,2011,11:31.
2Dellinger RP,Levy MM,Rhodes A,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2012.Crit Care Med,2013,41(2):580-637.
3Weber-Carstens S,Deja M,Bercker S,et al.Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients.Intensive Care Med,2007,33(4):730-3.
4Rajan P,Rivers JK.Varicella zoster virus.Recent advances in management.Can Fam Physician,2001,47:2299-304.
5Hatchette T,Tipples GA,Peters G,et al.Foscarnet salvage therapy for acyclovir-resistant varicella zoster:report of a novel thymidine kinase mutation and review of the literature.Pediatr Infect Dis J,2008,27(1):75-7.
6Jacobsen T,Sifontis N.Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection.Am J Health Syst Pharm,2010,67 (17):1417-25.
7Lu YC,Fan HC,Wang CC,et al.Concomitant use of acyclovir and intravenous immunoglobulin rescues an immunocompromised child with disseminated varicella caused multiple organ failure.J Pediatr Hematol Oncol,2011,33(8):e350-1.
8Maranich AM,Rajnik M.Varicella-specific immunoglobulin G titers in commercial intravenous immunoglobulin preparations.Pediatrics,2009,124(3):e484-8.
9Seward JF,Matin M,Vazquez M.Varicella vaccine effectiveness in the US vaccination program:a review.J Infect Dis,2008,197 Suppl 2:S82-9.
